Carl Zeiss Meditec AG (OTCMKTS:CZMWY) Short Interest Down 35.0% in February

Carl Zeiss Meditec AG (OTCMKTS:CZMWY) was the recipient of a significant drop in short interest in the month of February. As of February 28th, there was short interest totalling 1,300 shares, a drop of 35.0% from the February 13th total of 2,000 shares. Based on an average trading volume of 13,600 shares, the short-interest ratio is presently 0.1 days.

Analysts Set New Price Targets

Separately, The Goldman Sachs Group upgraded Carl Zeiss Meditec from a “sell” rating to a “buy” rating in a research note on Tuesday, March 11th.

Carl Zeiss Meditec Price Performance

OTCMKTS:CZMWY opened at $69.73 on Friday. The business has a 50 day moving average price of $57.86 and a 200-day moving average price of $61.13. Carl Zeiss Meditec has a fifty-two week low of $46.13 and a fifty-two week high of $133.15.

Carl Zeiss Meditec Announces Dividend

The company also recently declared an annual dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Friday, March 28th will be paid a dividend of $0.6246 per share. The ex-dividend date of this dividend is Friday, March 28th. This represents a dividend yield of 1%. Carl Zeiss Meditec’s dividend payout ratio is currently 32.64%.

Carl Zeiss Meditec Company Profile

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.